From: Osteopontin is a prognostic biomarker in non-small cell lung cancer
Parameter | Median serum OPN concentration (IQ Range) | p-value* |
---|---|---|
Gender | 0.02 | |
Female | 27.9 ng/ml (18.6) | |
Male | 35.2 ng/ml (19.5) | |
Age | 0.41 | |
< 65 years | 32.8 ng/ml (17.8) | |
> 65 years | 33.3 ng/ml (24.4) | |
Histology | 0.17 | |
Adenocarcinoma | 30.1 ng/ml (18.7) | |
Squamous cell carcinoma | 35.0 ng/ml (21.3) | |
Large cell carcinoma | 39.7 ng/ml (23.2) | |
pTNM | 0.42 | |
I | 31.0 ng/ml (20.7) | |
II | 35.8 ng /ml (16.9) | |
III | 35.2 ng/ml (22.2) | |
pT | 0.006 | |
pT1 | 28.0 ng/ml (25.2) | |
pT2 | 33.9 ng/ml (22.7) | |
pT3 | 35.2 ng/ml (21.7) | |
pT4 | 39.6 ng/ml (18.6) | |
pN | 0.79 | |
pN0 | 31.8 ng/ml (22.7) | |
pN1 | 35.4 ng/ml (15.6) | |
pN2 | 32.9 ng/ml (26.6) | |
Tumor size | 0.01 | |
≤ 3.0 cm | 29.1 ng/ml (17.9) | |
≥ 3.1 cm | 36.0 ng/ml (19.3) |